This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992 Mar;36(3):509-20.

doi: 10.1128/AAC.36.3.509.

Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition

K J Connolly¹, S M Hammer

Affiliations

PMID: 1377897
PMCID: PMC190549
DOI: 10.1128/AAC.36.3.509

Review

Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition

K J Connolly et al. Antimicrob Agents Chemother. 1992 Mar.

. 1992 Mar;36(3):509-20.

doi: 10.1128/AAC.36.3.509.

Authors

K J Connolly¹, S M Hammer

Affiliation

¹ Department of Medicine, New England Deaconess Hospital, Boston, Massachusetts.

PMID: 1377897
PMCID: PMC190549
DOI: 10.1128/AAC.36.3.509

No abstract available

PubMed Disclaimer

Similar articles

HIV regulatory proteins: potential targets for therapeutic intervention.
Rosen CA. Rosen CA. AIDS Res Hum Retroviruses. 1992 Feb;8(2):175-81. doi: 10.1089/aid.1992.8.175. AIDS Res Hum Retroviruses. 1992. PMID: 1540405 Review.
HIV-1 regulatory proteins: targets for novel drug development.
Ptak RG. Ptak RG. Expert Opin Investig Drugs. 2002 Aug;11(8):1099-115. doi: 10.1517/13543784.11.8.1099. Expert Opin Investig Drugs. 2002. PMID: 12150704 Review.
Combination gene therapy: synergistic inhibition of human immunodeficiency virus Tat and Rev functions by a single RNA molecule.
Lisziewicz J, Zeng G, Gratas C, Weinstein JN, Lori F. Lisziewicz J, et al. Hum Gene Ther. 2000 Apr 10;11(6):807-15. doi: 10.1089/10430340050015428. Hum Gene Ther. 2000. PMID: 10779158
Combinative interactions of a human immunodeficiency virus (HIV) Tat antagonist with HIV reverse transcriptase inhibitors and an HIV protease inhibitor.
Connell EV, Hsu MC, Richman DD. Connell EV, et al. Antimicrob Agents Chemother. 1994 Feb;38(2):348-52. doi: 10.1128/AAC.38.2.348. Antimicrob Agents Chemother. 1994. PMID: 7514858 Free PMC article.
Merged screening for human immunodeficiency virus Tat and Rev inhibitors.
Hamy F, Felder E, Lipson K, Klimkait T. Hamy F, et al. J Biomol Screen. 2001 Jun;6(3):179-87. doi: 10.1177/108705710100600308. J Biomol Screen. 2001. PMID: 11689114

See all similar articles

Cited by

Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes.
Malley SD, Grange JM, Hamedi-Sangsari F, Vila JR. Malley SD, et al. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11017-21. doi: 10.1073/pnas.91.23.11017. Proc Natl Acad Sci U S A. 1994. PMID: 7972000 Free PMC article.
Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin.
Kerb R, Brockmöller J, Staffeldt B, Ploch M, Roots I. Kerb R, et al. Antimicrob Agents Chemother. 1996 Sep;40(9):2087-93. doi: 10.1128/AAC.40.9.2087. Antimicrob Agents Chemother. 1996. PMID: 8878586 Free PMC article. Clinical Trial.
Antiviral therapy in human immunodeficiency virus infections. Current status (Part II).
Sandström E, Oberg B. Sandström E, et al. Drugs. 1993 May;45(5):637-53. doi: 10.2165/00003495-199345050-00002. Drugs. 1993. PMID: 7686460 Review.
Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells.
Mayaux JF, Bousseau A, Pauwels R, Huet T, Hénin Y, Dereu N, Evers M, Soler F, Poujade C, De Clercq E, et al. Mayaux JF, et al. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3564-8. doi: 10.1073/pnas.91.9.3564. Proc Natl Acad Sci U S A. 1994. PMID: 8170948 Free PMC article.

References

1. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5230-4 - PubMed
1. Ann Intern Med. 1990 Feb 15;112(4):254-61 - PubMed
1. J Infect Dis. 1990 Jun;161(6):1059-67 - PubMed
1. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6574-8 - PubMed
1. Science. 1990 Jan 26;247(4941):454-6 - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information